Therefore, our results suggested that QHYJ treatment inhibited CAF proliferation and the expression of CXCL1, 2, and 8, potentially reflecting the anti-cancer effects of QHYJ in pancreatic cancer. Here, CXCL1 is linked to familial pancreatic carcinoma.